Abstract
In cystic fibrosis, genomic variants can result in defective processing of the CFTR precursor mRNA. Due to the complexity of the splicing process, the evaluation of their pathological effect is an important aspect both in the diagnostic field and in the study of basic regulatory mechanism. Efficient and correct splicing of CFTR relies on a complex process that includes recognition within the nascent transcripts of a series of different splicing regulatory elements that frequently overlap with the coding sequences. Identification of these elements is essential to determine the pathological impact of splicing-affecting genomic variants. In this chapter, to evaluate the effect of CFTR DNA variations on the pre-mRNA splicing process, different tools based on hybrid minigenes will be described.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cartegni, L., Chew, S. L., and Krainer, A. R. (2002) Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285–298.
Pagani, F., Buratti, E., Stuani, C., and Baralle, F. E. (2003) Missense, nonsense and neutral mutations define juxtaposed regulatory elements of splicing in CFTR Exon 9. J. Biol. Chem. 278, 26580–26588.
Pagani, F., Stuani, C., Tzetis, M., Kanavakis, E., Efthymiadou, A., Doudounakis, S. et al. (2003) New type of disease causing mutations: The example of the composite exonic regulatory elements of splicing in CFTR exon 12. Hum. Mol. Genet. 12, 1111–1120.
Faustino, N. A., and Cooper, T. A. (2003) Pre-mRNA splicing and human disease. Genes Dev. 17, 419–437.
Pagani, F., and Baralle, F. E. (2004) Genomic variants in exons and introns: Identifying the splicing spoilers. Nat. Rev. Genet. 5, 389–396.
Buratti, E., Baralle, M., and Baralle, F. E. (2006) Defective splicing, disease and therapy: Searching for master checkpoints in exon definition. Nucleic Acids Res. 34, 3494–3510.
Cooper, T. A. (2005) Use of minigene systems to dissect alternative splicing elements. Methods 37, 331–340.
Pagani, F., Raponi, M., and Baralle, F. E. (2005) Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc. Natl. Acad. Sci. USA 102, 6368–6372.
Park, J. W., and Graveley, B. R. (2005) Use of RNA interference to dissect the roles of trans-acting factors in alternative pre-mRNA splicing. Methods 37, 341–344.
Hefferon, T. W., Broackes-Carter, F. C., Harris, A., and Cutting, G. R. (2002) Atypical 5′ splice sites cause CFTR exon 9 to be vulnerable to skipping. Am. J. Hum. Genet. 71, 294–303.
Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A. J. et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J. Clin. Invest. 101, 487–496.
Chu, C. S., Trapnell, B. C., Curristin, S., Cutting, G. R., and Crystal, R. G. (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat. Genet. 3, 151–156.
Buratti, E., and Baralle, F. E. (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337–36343.
Buratti, E., Dörk, T., Zuccato, E., Pagani, F., Romano, M., and Baralle, F. E. (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774–1784.
Ayala, Y. M., Pagani, F., and Baralle, F. E. (2006) TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett. 580, 1339–1344.
D’Ambrogio, A., Buratti, E., Stuani, C., Guarnaccia, C., Romano, M., Ayala, Y. M. et al. (2009) Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 37, 4116–4126.
Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M. et al. (2000) Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 275, 21041–21047.
Niksic, M., Romano, M., Buratti, E., Pagani, F., and Baralle, F. E. (1999) Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum. Mol. Genet. 8, 2339–2349.
Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q., and Krainer, A. R. (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568–3571.
Fairbrother, W. G., Yeh, R. F., Sharp, P. A., and Burge, C. B. (2002) Predictive identification of exonic splicing enhancers in human genes. Science 297, 1007–1013.
Fairbrother, W. G., Holste, D., Burge, C. B., and Sharp, P. A. (2004) Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biol. 2, E268.
Zhang, X. H., and Chasin, L. A. (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev. 18, 1241–1250.
Zhang, X. H., Kangsamaksin, T., Chao, M. S., Banerjee, J. K., and Chasin, L. A. (2005) Exon inclusion is dependent on predictable exonic splicing enhancers. Mol. Cell. Biol. 25, 7323–7332.
Venables, J. P., Koh, C. S., Froehlich, U., Lapointe, E., Couture, S., Inkel, L. et al. (2008) Multiple and specific mRNA processing targets for the major human hnRNP proteins. Mol. Cell. Biol. 28, 6033–6043.
Goina, E., Skoko, N., and Pagani, F. (2008) Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant. Mol. Cell. Biol. 28, 3850–3860.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Goina, E., Fernandez-Alanis, E., Pagani, F. (2011). Approaches to Study CFTR Pre-mRNA Splicing Defects. In: Amaral, M., Kunzelmann, K. (eds) Cystic Fibrosis. Methods in Molecular Biology, vol 741. Humana Press. https://doi.org/10.1007/978-1-61779-117-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-117-8_11
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-116-1
Online ISBN: 978-1-61779-117-8
eBook Packages: Springer Protocols